In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-17 of 17 for your search:
Drug:  exatecan mesylate
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CDR0000068880, DAIICHI-8951A-PRT031, MSKCC-02011, NCT00023972
2.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: DAIICHI-8951A-PRT007, MSKCC-98103, NCI-G99-1505
3.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CDR0000067146, DAIICHI-8951A-PRT012, SACI-IDD-99-03, SLLH-BHS-99-0020, NCT00004045
4.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CDR0000067147, DAIICHI-8951A-PRT009, JHOC-99062405, MSKCC-99014, NCT00003951
5.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CDR0000067148, DAIICHI-8951A-PRT011, MDA-ID-98308, NCT00004046
6.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CDR0000067258, DAIICHI-8951A-PRT008, MDA-DM-98265, NCT00004060
7.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 16 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CDR0000067329, DAIICHI-8951A-PRT016, MDA-ID-99145, MSKCC-99058, UCHSC-00891, NCT00004108
8.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CDR0000067525, DAIICHI-8951A-PRT015, MDA-DM-99247, NCT00004866
9.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: DAIICHI-8951E-PRT017, EU-99044, NCT00005091
10.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 16 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CDR0000067736, DAIICHI-8951A-PRT020, MDA-ID-99379, MSKCC-99110, SACI-IDD-99-31, UCHSC-00892, UTHSC-9905011256, NCT00005938
11.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CDR0000068663, DAIICHI-8951A-PRT028, SACI-IDD-00-27, UTHSC-0015011134, NCT00017212
12.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 15 to 75
Sponsor: Other
Protocol IDs: EORTC-62006, NCT00041236
13.

Phase: Phase II
Type: Treatment
Status: Completed
Age: Any age
Sponsor: Pharmaceutical / Industry
Protocol IDs: CDR0000271888, DAIICHI-8951A-PRT033, SJCRH-DXRMS, NCT00055939
14.

Phase: Phase II
Type: Treatment
Status: Completed
Age: Any age
Sponsor: Pharmaceutical / Industry
Protocol IDs: CDR0000271889, DAIICHI-8951A-PRT034, SJCRH-DXEWS, NCT00055952
15.

Phase: Phase I
Type: Treatment
Status: Completed
Age: Not specified
Sponsor: Pharmaceutical / Industry
Protocol IDs: CDR0000067149, DAIICHI-8951A-PRT014, MDA-ID-99013, NCI-V99-1556, NCT00004047
16.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 21 and under at diagnosis
Sponsor: Pharmaceutical / Industry
Protocol IDs: CDR0000067330, DAIICHI-8951A-PRT013, MSKCC-99071, UTHSC-9895011445, NCI-V99-1573, NCT00004212
17.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: UCLA-0201008, DAIICHI-8951A-PRT026, NCI-G02-2103, NCT00045318
New Search